Transoral (TOETVA) versus standard front‑neck (anterior cervical) thyroid surgery for lobectomy or thyroidectomy
Official title: Prospective Randomized Multicenter Trial Comparing the Efficacy and Safety of the Transoral Endoscopic Thyroidectomy by Vestibular Approach (TOETVA) Versus Anterior Cervical Thyroidectomy (AC)
Run by University Hospital, Lille · NCT07055191 · Data updated 2026-11-12
This trial will test whether the transoral (TOETVA) scar‑hiding approach works as well and is as safe as the standard front‑neck (anterior cervical) operation for adults needing lobectomy or thyroidectomy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 616 (estimated) |
| Sponsor | University Hospital, Lille Academic / other |
| Locations | 10 sites (Bobigny and 9 other locations) |
| Status | Recruiting |
| Started | November 7, 2025 |
| Main results expected | November 2028 |
| Study ends | November 2028 |
| Registry record updated | January 16, 2026 |
| Trial ID | NCT07055191 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–65 who need a lobectomy or thyroidectomy, have thyroid volume <60 mL and nodules <4 cm, have not had prior neck surgery, and can give informed consent and attend follow‑up are ideal candidates.
✕Probably not a fit
Patients with prior cervical surgery, identified malignant lymph nodes, required parathyroid procedures, severe life‑threatening comorbidities, or inability to consent (including non‑French speakers) are unlikely to benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional comparison enrolls adults 18–65 who need a lobectomy or thyroidectomy and have a thyroid volume under 60 mL and nodules under 4 cm. Participants receive either transoral endoscopic thyroidectomy by vestibular approach (TOETVA) or conventional anterior cervical (AC) thyroidectomy, with perioperative care and planned follow‑up. Outcomes include surgical efficacy, complication rates, cosmetic results, and recovery metrics such as pain and return to normal activities. The protocol excludes patients with prior cervical surgery, identified malignant lymph nodes, associated parathyroid procedures, or unstable severe illness, and is run at several French university and regional hospitals.
Why it matters
Potential benefit: If successful, the transoral approach could reduce visible neck scarring and improve cosmetic satisfaction while keeping safety and surgical results comparable.
How similar studies have gone: Existing case series and observational reports of TOETVA show comparable complication rates and improved cosmetic outcomes versus open neck surgery, but randomized direct comparisons are still limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with a surgical indication for lobectomy or thyroidectomy * Estimated thyroid volume measured by ultrasonography of less than 60 mL * Nodules suspected to be malignant measuring less than 4 cm * Patient aged between 18 and 65 years old * Patient who has benefited from an endocrinological evaluation, with a favorable opinion for TOETVA or AC Patient who understands and accepts the need for follow-up * Patient who agrees to be included in the study and who signs the informed consent form * Patient affiliated to a healthcare insurance plan Exclusion Criteria: * Patients refusing an alternative to AC or refusing AC * History of cervical surgery * Associated parathyroid surgery * Identification of malignant lymph nodes * Presence of a severe and evolutive life threatening pathology * Patients with unstable psychiatric disorder, under supervision or guardianship * Patient who does not understand French/ is unable to give consent * Patient not affiliated to a French or European healthcare insurance * Patient who has already been included in a trial which has a conflict of interests with the present study * Pregnant or breast-feeding patient * Patient incarcerated
Where it's running
-
CHU de Lille, Hôpital Huriez
Lille, France Recruiting -
AP-HP - Hôpital Avicennes
Bobigny, France Not yet recruiting -
Hôpital Franco-Britannique
Levallois-Perret, France Not yet recruiting -
CHU Dupuytren
Limoges, France Not yet recruiting -
CHU de Nantes - Hôtel Dieu
Nantes, France Not yet recruiting -
AP-HP - Hôpital Cochin
Paris, France Not yet recruiting
Show 4 more locations
-
Hôpital Lyon Sud
Pierre-Bénite, France Not yet recruiting -
CHU de Poitiers
Poitiers, France Not yet recruiting -
Polyclinique de la Côte Basque Sud
Saint-Jean-de-Luz, France Not yet recruiting -
CHRU de Nancy Brabois
Vandœuvre-lès-Nancy, France Not yet recruiting
Study contacts
- Study coordinator: Robert Caiazzo, Prof.
- Email: robert.caiazzo@chu-lille.fr
- Phone: +33 (0)3 20 44 55 15
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Opioid-Free vs Opioid-Based Anesthesia for Thyroid Surgery
This study tests whether a non-opioid anesthesia approach can match or improve outcomes for adults undergoing thyroidectomy.
-
Force feedback in robotic lung resection: does gentler instrument touch help recovery?
This study tests whether using Force Feedback instruments during robotic lobectomy or segmentectomy leads to faster recovery and fewer complications for adults undergoing these procedures.
-
Visual feedback in inspiratory muscle training after lobectomy
This study tests whether adding a mobile app with visual feedback to inspiratory muscle training helps lung cancer patients after lobectomy by improving motivation, adherence, and comfort while breathing.
-
Pre-incisional ropivacaine plus diprospan to relieve pain after VATS
This study tests whether injecting ropivacaine with diprospan before surgery can reduce postoperative pain for adults and children undergoing VATS lung surgery.
-
NIRAF-guided identification of parathyroids during thyroidectomy
A wearable near-infrared autofluorescence device is being tested to help surgeons find and protect the parathyroid glands during thyroid surgery in adults.
-
Tegileridine plus intercostal nerve block for pain after thoracoscopic lung removal
This trial will test whether giving a local intercostal nerve block together with patient-controlled tegileridine improves pain control for adults having thoracoscopic lobectomy or segmentectomy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.